The U.S. Centers for Disease Control and Prevention has issued a health advisory warning the public and healthcare officials about the increasing risk of dengue virus infections in the United States.
The Department of Drug Control has made a big move to address the rise in vector-borne illnesses like dengue and chikungunya during the monsoon season in the National Capital, Delhi
The US Food and Drug Administration approved Ixchiq, the first chikungunya vaccine, for individuals 18 years of age and older who are more vulnerable to mosquito-borne viruses.
